About Hospira
Hospira is a company based in Lake (United States) founded in 2004 was acquired by Pfizer in February 2015. The company has 2,658 employees as of December 31, 2014. Hospira has completed 3 acquisitions, including Javelin Pharmaceuticals, Mayne Pharma and Physiometrix. Hospira operates in a competitive market with competitors including 410 Medical, Ivenix, IRadimed, Belmont Medical Technologies and Linear Health Sciences, among others.
- Headquarter Lake, United States
- Employees 2658 as on 31 Dec, 2014
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
2658
as on Dec 31, 2014
-
Investments & Acquisitions
Javelin Pharmaceuticals
& 2 more
-
Acquired by
Pfizer
(Feb 05, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Hospira
Investors in Hospira
Hospira has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Pfizer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical products for treating multiple diseases are provided.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Hospira
Hospira has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Javelin Pharmaceuticals, Mayne Pharma and Physiometrix.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Novel drugs and formulations for pain disorders are developed.
|
1998 | ||||
|
Specialized products for electrodiagnostic neurological monitoring are developed and supplied.
|
1993 | ||||
|
Drug delivery systems are developed and marketed globally through partnerships.
|
1845 |
Financial Statements - Hospira
Hospira Comparisons
Competitors of Hospira
Hospira operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 410 Medical, Ivenix, IRadimed, Belmont Medical Technologies and Linear Health Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Rapid infusion systems are provided for critically ill patients.
|
|
| domain | founded_year | HQ Location |
Infusion management systems are developed with wireless web-based architecture.
|
|
| domain | founded_year | HQ Location |
Developer of IV Infusion system and patient monitoring systems for the MRI setting
|
|
| domain | founded_year | HQ Location |
Fluid management and critical care medical devices are developed.
|
|
| domain | founded_year | HQ Location |
IV breakaway valves are provided to prevent medical tubing dislodgement.
|
Latest news on Hospira
Frequently Asked Questions about Hospira
Hospira was founded in 2004.
Hospira is headquartered in Lake, United States.
David Endicott is the current CEO of Hospira.
As of Dec 31, 2014, the latest employee count at Hospira is 2,658.
Hospira was established in 2004 as a spin-off from Abbott Laboratories and acquired by Pfizer in September 2015, operating now as its subsidiary in the pharmaceutical sector. Injectable drugs, infusion technologies, and biosimilars are produced, along with IV sets, clinical integration services, infusion pumps, implementation support, and clinical software. Operations are based in Lake, United States, with a focus on healthcare delivery systems.
Hospira's top competitors include 410 Medical, IRadimed and Belmont Medical Technologies.
Hospira has made 3 acquisitions, including Javelin Pharmaceuticals, Mayne Pharma, and Physiometrix.
Hospira has 1 investor. Key investors include Pfizer.